New England Peptide Industries Company Profile

06:36 EDT 21st September 2018 | BioPortfolio

In a short time, we have changed the peptide industry. After spending years working with various biology and chemistry vendors, we recognized that scientists deserved a higher level of quality and service and we set out to create a company built around this vision. We have “raised the bar” for the entire industry by introducing innovative ordering and service programs and constantly exceeding our customers’ expectations. We are pleased to see that the entire industry has improved and are proud that it is largely in response to our approach.New England Peptide, Inc. is a new generation peptide company with a brand new, highly automated facility and a dedication to service unsurpassed in the industry. We have been able to consistently offer faster turn-around times, easy ordering options (including the introduction of our internet ordering option), simple pricing schemes and personalized friendly service. All with a dedication to quality that satisfies even the most discriminating scientists.


65 Zub Lane
United States of America


Phone: 978-630-0020
Fax: 978-630-0021

News Articles [1098 Associated News Articles listed on BioPortfolio]

Breakthrough for Peptide Medication: New Strategy Makes Peptide Active Agents Available Orally

Breakthrough for peptide medication - The “Holy Grail” of peptide chemistry: Making peptide active agents available orally. Peptides, short amino acid chains that control many functions in...

Merck taps Italian CRO IRBM for peptide drug development

IRBM and Merck have signed a new agreement in the peptide therapeutics area through which the Italian CRO will identify potential peptide leads for a specific Merck target.

New England Precision Stability Storage Facility Validated

ICH-specified environmental conditions available for products in all industries

IRBM and Merck & Co Cooperate on Peptides

Italian research organization IRBM has signed a new agreement with Merck & Co on peptides therapeutics, extending a collaboration begun in 2010. In the newest round, it will leverage its expertise...

This Oxford Biotech is Using mRNA to Find New Peptide Drugs

Today, we’re in Oxford, UK, visiting Orbit Discovery. The biotech develops peptide drugs for chronic diseases using mRNA display technologies by linking proteins to their encoding DNA. Mission:...

NHS England appoints national clinical advisor for primary care

NHS England has appointed a specialist GP to encourage the spread of innovations that integrate health and social care throughout England.

Over 400,000 sexually transmitted infections reported in England in 2017, PHE report reveals

The number of confirmed cases of gonorrhoea and syphilis in England in 2017 rose by 22% and 20%, respectively, according to data released by Public Health England.

Peptide therapeutics: current statusand future directions

Here, the authors discuss the current status, strengths, and weaknesses of peptides as medicines and the emerging new opportunities in peptide drug design and development.

Drugs and Medications [385 Associated Drugs and Medications listed on BioPortfolio]

Dawnmist hypoallergenic petroleum [Donovan Industries, Inc.]

DawnMist Hypoallergenic Petroleum Jelly

Purell advanced green certified instant hand sanitizer [GOJO Industries, Inc.]

PURELL Advanced Green CertifiedInstant Hand Sanitizer Foam

Purell advanced green certified instant hand sanitizer [GOJO Industries, Inc.]

PURELL Advanced Green CertifiedInstant Hand Sanitizer

Purell advanced skin nourishing instant hand sanitizer [GOJO Industries, Inc.]

PURELL Advanced Skin NourishingInstant Hand Sanitizer Foam

Dawnmist antiperspirant and deodorant [Donovan Industries, Inc.]

DawnMist Antiperspirant Deodorant Spray

PubMed Articles [2287 Associated PubMed Articles listed on BioPortfolio]

Correction: Borinic acid catalysed peptide synthesis.

Correction for 'Borinic acid catalysed peptide synthesis' by Tharwat Mohy El Dine et al., Chem. Commun., 2015, 51, 16084-16087.

A network analysis of indirect carbon emission flows among different industries in China.

Indirect carbon emissions account for a large ratio of the total carbon emissions in processes to make the final products, and this implies indirect carbon emission flow across industries. Understandi...

Late-Stage Peptide Diversification by Position-Selective C-H Activation.

The late-stage modification of structurally-complex peptides bears great potential for drug discovery, crop protection and pharmaceutical industries, among others. While traditional approaches had thu...

An anthraquinone-enzyme-peptide hybrid as a photo-switchable enzyme.

A purpose-designed anthraquinone-horseradish peroxidase (HRP)-cell penetrating peptide hybrid 1 showed high and effective cell permeability. Furthermore, 1 exhibited enzymatic activity without photo-i...

Isolation and Identification of Tyrosinase Inhibitory and Copper-Chelating Peptides from Hydrolyzed Rice Bran-Derived Albumin.

Rice bran albumin (RBAlb), which showed higher tyrosinase inhibitory activity than other protein fractions, was hydrolyzed with papain to improve the bioactivity. The obtained RBAlb hydrolysate (RBAlb...

Clinical Trials [880 Associated Clinical Trials listed on BioPortfolio]

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

To evaluate the chemical efficacy and safety of intranasally administered peptide T on neurocognitive function in HIV seropositive individuals. Previous studies have shown that treatment ...

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

To evaluate safety and immunogenicity of 2 different HIV-1 peptide candidate vaccines, the UBI HIV-1 MN PND peptide immunogen and the UBI microparticulate monovalent HIV-1 MN branched pept...

Patient-individualized Peptide Vaccination in Combination With Lenalidomide After First Line Therapy of CLL

The aim of this study is to induce a peptide-specific immune response in chronic lymphatic leukaemia (CLL) patients by multi-peptide vaccination with a patient-individualized peptide cockt...

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

Patients with metastatic melanoma who are HLA-A201+ will be immunized with a modified peptide from the gp100 molecule that contains a signal sequence designed to improve peptide presentati...

Immunotherapy of Stage III/IV Melanoma Patients

The purpose of this study is to determine whether vaccination with melanoma antigen peptides [Melan-A/Mart-1 (both EAA and ELA), NY-ESO-1b analog, Long NY-ESO-1 LP and MAGE-A10] and Montan...

Companies [1306 Associated Companies listed on BioPortfolio]

New England Peptide Industries

In a short time, we have changed the peptide industry. After spending years working with various biology and chemistry vendors, we recognized that scientists deserved a higher level of quality and ser...

Peptide Resource Page

Welcome to the Peptide Resource Page (PRP). Founded in 2004, the PRP is designed to help researchers and educators navigate through the maze of peptide related websites. Search our pages to find pepti...

New England Peptide

New England Peptide, founded in 1998, designs and produces custom peptides and polyclonal antibodies for drug and vaccine discovery organizations worldwide. Headquartered in the B...

Lifetein LLC

LifeTein LLC, located in Edison, New Jersey, was founded for its global custom peptide synthesis services and antibody production services on the principles of understanding life one protein at a time...

RS Synthesis, LLC

RS Synthesis is a world-class supplier of custom peptide products and services. Our high quality product line includes, custom peptide synthesis, catalog peptides, peptide libraries, production scale...

More Information about "New England Peptide Industries" on BioPortfolio

We have published hundreds of New England Peptide Industries news stories on BioPortfolio along with dozens of New England Peptide Industries Clinical Trials and PubMed Articles about New England Peptide Industries for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of New England Peptide Industries Companies in our database. You can also find out about relevant New England Peptide Industries Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record